Company Summary: Healthier Choices Management Corp. (HCMC)

Business Focus

• HCMC is primarily engaged in the development, marketing, and monetization of proprietary intellectual property related to vaping technologies, specifically through its patented products like Q-Cup™ and Imatine.
• The Company markets patented Q-Cup™ technology, which includes a small quartz concentrate cup that is heated externally without contact, providing efficiency for consumers vaping cannabis or CBD concentrates.
• HCMC aims to generate revenue via royalty and licensing agreements through its wholly owned subsidiary HCMC Intellectual Property Holdings, LLC, which manages its patent portfolio, trademarks, and other IP assets.

Product Development & IP Portfolio

• The company has developed and trademarked multiple patents, including three US patents awarded in October 2018 related to the Q-Cup™ technology.
• It manages a suite of patent applications pending US and international patents to expand protection.
• Continual product innovation includes development of hardware containers and accessories based on its patented tech.

Vaporizer Business Operations

• Marketed through The Vape Store, Inc., a wholly owned subsidiary.
• No manufacturing capabilities; products are made by third-party manufacturers based on HCMC’s specifications.
• The company has historically filed patent infringement lawsuits to protect its IP, including cases against Philip Morris USA and R.J. Reynolds Vapor Company.

Strategic Initiatives

• Focus on monetizing its patent portfolio by licensing products and forming strategic partnerships.
• International expansion of patent coverage to key global markets.
• Ongoing product development to improve existing hardware and hardware containers based on patented tech.
• Active enforcement of its patents against alleged infringers.

Market & Competition

• Competes within the fragmented vaporizer and e-liquid industry against large tobacco companies like Altria, JT International, Imperial Tobacco, and Reynolds American.
• The company faces barriers like intense competition, established sales channels of larger competitors, and ongoing regulatory challenges.

Financial Highlights

• As of April 14, 2025:
  • Shares Outstanding: Approximately 481 billion (specifically 481,266,632,384 as of the latest date).
  • Stock Price: $0.0001 per share on OTC Pink Marketplace.
  • Market Capitalization: Approximately $47.9 million based on the recent stock price.
  • Revenue (2024): $501, which is minimal and reflects de minimis sales.
  • Net Loss (2024): Approximately $8.1 million from continuing operations.
  • Cash on hand: About $1.2 million as of December 31, 2024.
  • Negative Working Capital: Approximately $0.7 million.
  • No dividends are paid or expected; the company intends to retain earnings for operations and growth.

Management & Employees

• Key Executives:
  • Jeffrey Holman: CEO and Chairman, with significant industry experience and a legal background.
  • John A. Ollet: CFO, CPA with finance experience at other companies.
  • Christopher Santi: President and COO.
• Directors:
  • Clifford J. Friedman
  • Dr. Anthony Panariello
• The company’s total employee count is not explicitly stated; most of the senior management are also Board members and involved in strategic IP and operational decisions.

Business Status

• The company has developed a niche IP portfolio, faced ongoing legal challenges related to patent enforcement, and incurred significant operating losses.
• It operates as a small-cap OTC traded company, with all operations focused on its IP licensing and vaping hardware innovations.
• No mention of significant customer base size, revenue from product sales, or specific employee count figures. The financial data shows minimal direct sales, indicating primary revenue streams are likely licensing and ongoing IP enforcement activities.

Note: All data is directly from the 10-K filing provided, with no speculative projections or external assumptions.